Literature DB >> 22655580

[Workplace testing of drugs of abuse and psychotropic drugs].

P Mura1, E Saussereau, B Brunet, J-P Goullé.   

Abstract

In France, workplace testing of drugs of abuse and psychotropic drugs is rarely performed; meanwhile it is a major public health problem. Furthermore, France is the European country that has been associated with the highest increase of the use of drugs of abuse, particularly cannabis. So workplace biological screening of drugs of abuse and of psychotropic drugs exposure is of major concern. New analytical techniques have been developed during the last years. The authors will consider analytical screening of drugs of abuse and particularly the comparison of analytical techniques applied to urine and saliva. The advantages and the disadvantages of these two matrices will be considered. Urinary and blood quantification will be reviewed, but also the interest of hair testing to explore chronic exposure. The research of psychotropic drugs in biological fluids is also a part of this paper. New analytical trends are promising and complete analysis of these substances will be soon routinely possible in blood using a single spot test.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Mesh:

Substances:

Year:  2012        PMID: 22655580     DOI: 10.1016/j.pharma.2012.03.002

Source DB:  PubMed          Journal:  Ann Pharm Fr        ISSN: 0003-4509


  3 in total

1.  Occupational Injuries and Use of Benzodiazepines: A Systematic Review and Metanalysis.

Authors:  Sergio Garbarino; Paola Lanteri; Nicola Luigi Bragazzi; Giovanni Gualerzi; Matteo Riccò
Journal:  Front Hum Neurosci       Date:  2021-05-13       Impact factor: 3.169

Review 2.  Marijuana: current concepts(†).

Authors:  Donald E Greydanus; Elizabeth K Hawver; Megan M Greydanus; Joav Merrick
Journal:  Front Public Health       Date:  2013-10-10

3.  Urine specimen validity test for drug abuse testing in workplace and court settings.

Authors:  Shin-Yu Lin; Hei-Hwa Lee; Jong-Feng Lee; Bai-Hsiun Chen
Journal:  J Food Drug Anal       Date:  2017-02-14       Impact factor: 6.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.